Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial
European Heart Journal, 2025
Berger M., MacNamara A., Ferreira J., Kolkhof P., Voss S., Skubala A., Scalise A., Goea L., Nkulikiyinka R., Pitt B., Ix J., Rossing P., Coward R., Zannad F., Heerspink H.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
CVD | Pathophysiology | Plasma |  Olink Explore 3072/384 |
Abstract
No abstract – Rapid Communication